Please take a moment and listen to the introductory video on your left. Then, view the video below and follow the instructions for the quiz.

The video below from the Psychedelic Science in the 21st Century is available for continuing education credit through the co-sponsorhip of the Mulitdisciplinary Association for Psychedelic Studies and the Spiritual Competency Resource Center for many physicians, psychologists, social workers, MFTs, nurses and other healthcare professionals.


    1. Watch the video on your left. There is no charge for viewing the video
    2. Answer the questions below.
    3. When finished, press the Score My Quiz button. After that you will have an option to checkout and print your CE certificate.*
    4. To view CE information click here

Michael Mithoefer, MD: MDMA-Assisted Psychotherapy for Treatment of PTSD: Results from US Pilot Study

Course Presenter(s):
Author(s): Michael Mithoefer, M.D. | (click author name for biography)

Course Description: Dr. Mithoefer reports data from the completed, randomized, double-blind, placebo-controlled pilot study of MDMA-assisted psychotherapy in 21 subjects with treatment-resistant PTSD, and on the subsequent long-term follow up of these subjects > 1 year after study completion. He also describes the design and progress of a dose-response MDMA-assisted psychotherapy study in US war veterans that he expects to complete in 2011.
Biography of Presenter:

Michael Mithoefer, M.D.
, is a psychiatrist who practices in Charleston, SC, where he divides his time between clinical research and outpatient clinical practice specializing in treating posttraumatic stress disorder with an emphasis on experiential methods of psychotherapy. He is a Grof certified Holotropic Breathwork Facilitator and is trained in EMDR and Internal Family Systems Therapy. He and his wife, Annie Mithoefer, recently completed a MAPS- sponsored Phase II clinical trial testing MDMA-assisted psychotherapy for Posttraumatic Stress Disorder (PTSD). They will soon begin a second trial with veterans who have PTSD resulting from service in the US Armed Forces, and are conducting psychotherapy training programs for MAPS researchers. He is medical monitor for MAPS-sponsored clinical trials in Europe, the Middle East and Canada. Before going into psychiatry in 1995 he practiced emergency medicine for ten years, served as medical director of the Charleston County and Georgetown County Emergency Departments and has held clinical faculty positions at the Medical University of South Carolina. He is currently board certified in Psychiatry, Emergency Medicine and Internal Medicine.

Date of original release: April 18, 2010
Termination date (date after which enduring material is no longer certified for credit): April 17, 2012

Michael Mithoefer, M.D. from MAPS: Psychedelic Science on Vimeo.

True/False Comprehension Quiz

The decreased fear response induced by MDMA administration may be useful in the treatment of PTSD since this condition involves exaggerated and uncontrolled fear responses.
The pharmacological effects of MDMA include serotonin release, 5HT2 receptor stimulation, and increase in levels of the neurohormones oxytocin, prolactin and cortisol
The study was conducted by having the patient take the MDMA in a setting involving recreating the trauma situation in as real life a way as possible
Each subject had two 90-min introductory sessions within 6 weeks before the first experimental session to prepare them for the structure of the sessions, the approach to therapy and possible effects of MDMA.
The method of psychotherapy followed principles developed by Stanislav Grof, MD for entering into a nonordinary state of consciousness by creating a safe and supportive setting for the MDMA session.
In Stage 1, there were eight integration sessions focused on discussing the experimental sessions, additional emotional processing and helping subjects incorporate any insights or new perspectives into their daily lives.
There was over a 30% decrease in PTSD symptoms on the measures used in this study.
There were several drug-related serious adverse events, adverse neurocognitive effects and clinically significant blood pressure increases

Rate this Course:
Rating of this course out of 23 votes:46%


Spiritual Competency Resource Center Website